NASDAQ:CALC
CalciMedica, Inc.
CalciMedica, Inc. reported net income of −$29.6M in fiscal 2025. Free cash flow was −$21.2M, and the diluted share count rose 33.5%.Summary generated from CalciMedica, Inc.'s SEC filings. Latest annual report filed Mar 3, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−761.0%
Debt / equityn/a
Free cash flow−$21.2M
FCF marginn/a
Share count change+33.5%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating income | −36 | −14 | −38 | −24 | −23 |
| Net income | −36 | −8 | −34 | −14 | −30 |
| Free cash flow | −32 | −12 | −26 | −21 | −21 |
Recent filings
- 4Insider transaction report
Oct 5, 2026 - 4Insider transaction report
Oct 5, 2026 - 8-KOther events
Sep 30, 2026 - 8-KOther events
Sep 16, 2026 - 8-KOther events
Sep 2, 2026 - 8-KAmendment to articles or bylaws
Aug 27, 2026 - 8-KDirector or officer change
Aug 20, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 11, 2026